Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check2 days agoChange DetectedThe page’s interface revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any change to the underlying trial record.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices including Revision: v3.4.1. These are administrative updates to the site history and do not change core study information or user-facing content.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page now displays a government-funding notice and updates the site revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.